Tumor Immunology
Immunology for tumors describes the interaction between
immune system cells and
tumor cells. Understanding such interactions is important for the development of new
cancer treatment therapies.. The immunological pathways involved in the growth of
cancer are extremely diverse including tissue-resident and
cells originating from the blood. The human
immune system mounts natural endogenous responses to highly immunogenic
tumor cells through a series of steps, including the presentation of tumor antigens to T
cells via antigen-presenting
cells (APCs), priming and activation of T
cells in the lymph nodes, trafficking and infiltration of T
cells into
tumor beds, the recognition of
cancer cells by T cells, the development of antigen-specific effects.
High Impact List of Articles
-
Procollagen III amino terminal propeptide (PIIINP): A marker of MTX induced liver fibrosis in rheumatoid arthritis patients?
Neama M Lotfy, Noran O El-Azizi, Marwa A Nassef, Hanaa A Amer, Hala G Mohamed, & Amany M Mansour
Research Article: International Journal of Clinical Rheumatology
-
Procollagen III amino terminal propeptide (PIIINP): A marker of MTX induced liver fibrosis in rheumatoid arthritis patients?
Neama M Lotfy, Noran O El-Azizi, Marwa A Nassef, Hanaa A Amer, Hala G Mohamed, & Amany M Mansour
Research Article: International Journal of Clinical Rheumatology
-
Research highlights in interventional cardiology (2015)
T Konrad, T Munzel, T Rostock & FP Schmidt
Research Highlights: Interventional Cardiology
-
Research highlights in interventional cardiology (2015)
T Konrad, T Munzel, T Rostock & FP Schmidt
Research Highlights: Interventional Cardiology
-
A role for TGF-β in osteoarthritis-related pain?
EN Blaney Davidson & PM van der Kraan
Editorial: International Journal of Clinical Rheumatology
-
A role for TGF-β in osteoarthritis-related pain?
EN Blaney Davidson & PM van der Kraan
Editorial: International Journal of Clinical Rheumatology
-
From a pacemaker in a donkey to valve disease research in humans
P Pibarot
Interview: Interventional Cardiology
-
From a pacemaker in a donkey to valve disease research in humans
P Pibarot
Interview: Interventional Cardiology
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical